Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
20.53B
Market cap20.53B
Price-Earnings ratio
22.17
Price-Earnings ratio22.17
Dividend yield
1.67%
Dividend yield1.67%
Average volume
1.08M
Average volume1.08M
High today
$189.75
High today$189.75
Low today
$184.49
Low today$184.49
Open price
$189.75
Open price$189.75
Volume
1.10M
Volume1.10M
52 Week high
$197.55
52 Week high$197.55
52 Week low
$150.14
52 Week low$150.14

Stock Snapshot

As of today, Quest Diagnostics(DGX) shares are valued at $184.65. The company's market cap stands at 20.53B, with a P/E ratio of 22.17 and a dividend yield of 1.7%.

During the trading session on 2026-01-21, Quest Diagnostics(DGX) shares reached a daily high of $189.75 and a low of $184.49. At a current price of $184.65, the stock is +0.1% higher than the low and still -2.7% under the high.

Trading volume for Quest Diagnostics(DGX) stock has reached 1.1M, versus its average volume of 1.08M.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $150.14.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $150.14.

DGX News

Simply Wall St 23h
Quest Diagnostics Expands At Home STI Testing As Valuation Signals Upside Potential

Quest Diagnostics (NYSE:DGX) has partnered with Visby Medical to offer an at-home, FDA authorized PCR test focused on women's sexual health. The new test targe...

Quest Diagnostics Expands At Home STI Testing As Valuation Signals Upside Potential
Simply Wall St 4d
Is Quest Diagnostics Using At-Home STI Tests to Redefine Its Consumer Health Strategy?

In November 2025, Visby Medical announced that Quest Diagnostics’ consumer platform, questhealth.com, added the FDA-authorized at-home Visby Women’s Sexual Heal...

Is Quest Diagnostics Using At-Home STI Tests to Redefine Its Consumer Health Strategy?

Analyst ratings

55%

of 22 ratings
Buy
40.9%
Hold
54.5%
Sell
4.5%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.